Sumit Dhole – The missing ecology in gene drive research | GES Colloquium
Poe 202 (North Campus) 2310 Katharine Stinson Dr., Raleigh, NC, United StatesGES Fall Colloquium, details forthcoming
GES Fall Colloquium, details forthcoming
Developing data-intensive algorithms and applying diverse modeling and optimization tools to tackle the national grand challenge to decarbonize our energy needs while securing a sustainable and resilient supply chain infrastructure.
This talk will describe six principles for the proper governance of gene editing, addressing issues such as transparency, stakeholder engagement, government oversight, and voluntary stewardship, that were adopted by six US non-governmental organizations.
AgBioFEWS Cohort 3 Fellows bring together a panel of speakers to discuss how the emerging field of GE might influence international markets and impact society.
As different groups work out whether and how to pursue gene drive organisms, Sam Weiss Evans explores the ways STS researchers can enrich the attention to diverse perspectives, equity, vulnerability, and learning.
The Goal is to have fully secure and accessible Plant Genetic Resources for Food and Agriculture where there is the potential for a multi-lateral flow of germplasm and knowledge among the participants, basically, all human beings on Earth.
Ethiopian mustard (Brassica carinata) can produce substantial amounts of aviation fuel and soil carbon benefits when grown as a winter crop in the southeastern US.
The Genetic Engineering and Society Colloquium is a seminar series that brings in speakers to present and stimulate discussion on a variety of topics related to existing and proposed biotechnologies and their place within broader societal changes.
A discussion of the key ethical considerations in the governance of CRISPR technologies for agriculture and the environment, including for gene-edited plants and gene drive organisms.
Addressing the energy problem of greenhouse agriculture
A presentation of data on using gene addition and gene editing technology to treat patients with sickle cell disease and transfusion dependent beta thalassemia.
The Genome Writers Guild asks the question: How do we promote responsible use of genome engineering?